GP Update on Inflammatory Bowel Disease
description
Transcript of GP Update on Inflammatory Bowel Disease
![Page 1: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/1.jpg)
Clare Donnellan
Consultant Gastroenterologist Leeds Teaching Hospitals
![Page 2: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/2.jpg)
Key features of IBD History & examination Investigations Treatment including DMARDs Flares – what should GPs do? What’s new?
![Page 3: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/3.jpg)
![Page 4: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/4.jpg)
Incidence UC 10 per 100,000
Incidence CD 6-7 per 100,000
Prevalence 400 per 100,000 (250/150)
Onset between 15 and 40 years of age Similar in males and females
![Page 5: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/5.jpg)
Ulcerative colitis◦ Proctitis◦ Left-sided disease◦ Pan-colitis
Crohn’s Disease◦ Affects anywhere
Small bowel (80%) Small & Large bowel (50%) Peri-anal disease (35%) More likely to get complications
IBD-unclassified 5%
![Page 6: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/6.jpg)
Genetics◦10-25% of patients have at least one
other family member affected◦No particular gene identified in UC
◦NOD2/CARD15 gene abnormalities in CD Terminal ileal disease Possibly more chance of requiring surgery
![Page 7: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/7.jpg)
Environmental factors◦ Smoking
Protective for UC Worsens outcome for CD
◦ Appendicectomy Protective for UC Unlikely effect for CD
◦ Diet?◦ Bacteria?
![Page 8: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/8.jpg)
Episcleritis/scleritis◦ 2 to 5% of patients◦ Activity linked to GI tract
Anterior uveitis◦ 0.5-3%, but much more serious◦ Females:males 4:1◦ 75% of patients have arthritis◦ Activity not linked to GI tract
![Page 9: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/9.jpg)
Erythema nodosum◦Most common skin
manifestation of IBD (up to 15%)
◦Typically flares at same time as GI symptoms
Pyoderma grangrenosum◦Up to 5% of patients◦More chronic course
![Page 10: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/10.jpg)
Related to GI activity◦ Peripheral arthritis◦ Episcleritis/scleritis◦ Erythema nodosum
Not related to GI activity◦ Spondylitis/sacroiliitis◦ Anterior uveitis◦ Pyoderma Gangrenosum
![Page 11: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/11.jpg)
![Page 12: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/12.jpg)
Bloody diarrhoea or prolonged diarrhoea (-ve MC&S)◦ Abdominal pain◦ Urgency◦ Tenesmus
If 1st presentation◦ Stool frequency/day & night◦ Systemic features◦ Weight loss◦ Fever◦ Extra-GI features
◦ Travel◦ DH (Abx, NSAIDs◦ FH◦ SH
![Page 13: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/13.jpg)
‘The professional patient’◦ Is it like a ‘usual’ flare?◦ What are the usual strategies?◦ IBD Helpline 0113 206 8679
Is it severe?◦ Truelove and Witts criteria
≥6 bloody stools per day Systemic toxicity (HR>90, T>37.8, ESR>30) or
Hb<10.5 NEEDS ADMITTING for IV steroids
![Page 14: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/14.jpg)
Much more challenging to ΔΔ IBD vs. IBS….◦ Abdominal pain◦ Diarrhoea (ask re: nocturnal symptoms)◦ Weight loss◦ Systemic features◦ Extra-GI manifestations
![Page 15: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/15.jpg)
‘The professional patient’◦ Is it like a ‘usual’ flare?◦ What are the usual strategies?◦ IBD Helpline 0113 206 8679
![Page 16: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/16.jpg)
Systemically unwell?◦ Fever◦ Tachycardia
Dehydration BMI/weight Abdominal tenderness/distension/bowel
sounds Palpable mass Peri-anal examination
![Page 17: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/17.jpg)
Follow ‘usual’ strategy Call helpline (pt or GP) if concerned
◦ Advice◦ Early access to IBD clinic
Admit if systemically unwell
![Page 18: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/18.jpg)
![Page 19: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/19.jpg)
FBC, U&E, LFT, CRP Haematinics Stool MC&S Stool C diff (Stool OC&P)
Urgent referral to gastroenterology if high index of suspicion
![Page 20: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/20.jpg)
UC◦ Bloods◦ AXR◦ Urgent stool cultures◦ Urgent flexible sigmoidoscopy within 24 hours◦ (CMV PCR and CMV on biopsies)◦ CT if risk of perforation
![Page 21: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/21.jpg)
Crohn’s◦ Varies on symptoms/distribution
◦ Low threshold for CT abdo/pelvis
◦ Flexible sigmoidoscopy often unhelpful
◦ MR pelvic if abscess/fistulising disease
![Page 22: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/22.jpg)
Small bowel◦ Small bowel meal if suspected CD/suspected SB
CD◦ MR enterography (enteroclysis) if known SB CD◦ OGD◦ Ultrasound◦ Wireless capsule endoscopy◦ Isotope (labelled white cell scans)
Colon◦ Colonoscopy◦ CT colonography
![Page 23: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/23.jpg)
![Page 24: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/24.jpg)
![Page 25: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/25.jpg)
5-ASAs◦ Prescribe by drug name◦ But lower cost equivalents (Asacol = Mesren =
Octasa)
◦ Dose Asacol 2.4 g vs. 4.8 g Minimum 2 g for maintenance (1.2 g cancer prevention)
◦ OD as effective and better adherence for maintenance
◦ Tablets + Local therapy often avoids steroids 5-ASA enemas better than steroid enemas
![Page 26: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/26.jpg)
DMARDs◦ Azathioprine 2-2.5 mg/kg◦ 6-mercaptopurine 1-1.5 mg/kg
◦ Weekly bloods for 4/52◦ Then monthly◦ Then 3 monthly
◦ S/E (Raised MCV and lymphopaenia)
![Page 27: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/27.jpg)
Other DMARDs◦ Methotrexate
Evidence not great
◦ Mycophenolate Some evidence
![Page 28: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/28.jpg)
Optimise 5-ASAs first if sole treatment◦ Maximise dose◦ Add in local therapy (5-ASAs, not steroids)
Prednisolone 30 mg daily with Ca/Vit D cover◦ More prolonged course
If not settling (or severe UC) IV steroids
![Page 29: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/29.jpg)
Is it severe?◦ Truelove and Witts criteria
≥6 bloody stools per day Systemic toxicity (HR>90, T>37.8, ESR>30) or
Hb<10.5 NEEDS ADMITTING for IV steroids Colectomy rate approx. 30%
![Page 30: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/30.jpg)
Day 3 (Travis criteria)◦ If stool frequency > 8 or CRP > 45◦ 85% chance of colectomy
3 options◦ Surgery
◦ Infliximab as a bridge to Aza/6-MP◦ Cyclosporin
![Page 31: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/31.jpg)
Ciclosporin/infliximab◦ 70 – 80% leave hospital with colon◦ 30% long-term
Infection risks
![Page 32: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/32.jpg)
No role for 5-ASAs except if mild colitis ? Role after surgery in preventing relapse
![Page 33: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/33.jpg)
If luminal disease◦ Oral steroids◦ IV steroids if no response
◦ Still no response? No role for ciclosporin Give infliximab +/- azathioprine for 1 year
◦ Nutrition support key
![Page 34: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/34.jpg)
If peri-anal disease◦ Drain any sepsis◦ Antibiotics◦ Seton sutures
◦ Escalate therapy as appropriate
![Page 35: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/35.jpg)
DMARDS◦ Azathioprine◦ Methotrexate (s/c)◦ Mycophenolate◦ Tacrolimus
Surgery◦ For complications
Biologicals◦ Infliximab◦ Adalimumab
(Humiara)
◦ NICE assessment at 1 yr
![Page 36: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/36.jpg)
Liquid diet for Crohn’s Bone protection Endoscopic dilatation of strictures
![Page 37: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/37.jpg)
![Page 38: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/38.jpg)
Calprotectin◦ Diagnosis◦ Activity assessment
Azathioprine metabolite levels◦ Optimise dose◦ Minimise side-effects◦ ? Reduce number of patients needing biologicals
Leucocytapheresis
Mucosal healing
![Page 39: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/39.jpg)
Guided self-management
More nurse-led clinics
Reduce follow-up waits…
Less ‘black and white’ in/out of service
![Page 40: GP Update on Inflammatory Bowel Disease](https://reader036.fdocuments.us/reader036/viewer/2022070421/56816028550346895dcf2f67/html5/thumbnails/40.jpg)
Significant morbidity
Early, focused management
Use helpline 0113 206 8679
Admit if systemically unwell Stool cultures Appropriate steroid course